Global Antibacterial Drugs Market - Forecasts to 2026
Browse 117 Market Data Tables and 117 Figures spread through 189 Pages and in-depth TOC on “Global Antibacterial Drugs Market” - Forecast to 2026" https://www.globalmarketestimates.com/market-report/antibacterial-drugs-market-3477
By Drug Class (Beta-Lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, Phenicols, Others), By Route of Administration (Parenteral, Enteral, Oral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Region (North America, Europe, Asia Pacific, CSA, and the Middle East & Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis
Key Market Insights:
• The β-Lactams segment will hold a lion’s share in the market from 2021 to 2026
• The retail pharmacies segment is expected to capture the largest share of the market compared to the other distribution channels throughout the forecast period.
• In October 2020, Pfizer, Inc. collaborated with Arixa Pharmaceuticals Inc. The company is engaged in developing next-generation oral antibiotics for drug-resistant Gram-negative infections.
• AbbVie Inc, Basilea Pharmaceutica Ltd., Bayer AG, Boston Pharmaceuticals Inc., Bristol Myers Squibb Company, Debiopharm Group, Eli Lilly and Company, GlaxoSmithKline PLC, Iterum Therapeutics PLC, Johnson & Johnson Service, Inc., Kyorin Pharmaceutical Co., Ltd, Melinta Therapeutics, Merck & Co., Inc., Micurx Pharmaceutical Inc., Novartis International AG, Pfizer, Inc, R-Pharm Group, Sanofi SA, Shionogi Inc, Sichuan Pharmaceutical Co., Ltd, TenNor Therapeutics, Theravance Biopharma, Inc., VenatoRx Pharmaceuticals, Inc, and Wockhardt Ltd., among others are some of the key players in the antibacterial drugs market
Browse the Report @ https://www.globalmarketestimates.com/market-report/antibacterial-drugs-market-3477
Drug Class Outlook (Revenue, USD Billion, 2021 - 2026)
Route of Administration Outlook (Revenue, USD Billion, 2021 - 2026)
Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2026)
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
Regional Outlook (Revenue, USD Billion, 2021 – 2026)
• The U.S.
• Rest of Europe
• South Korea
• Rest of APAC
Central & South America
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of MEA
Contact: Yash Jain
Email address: firstname.lastname@example.org
Phone Number: +16026667238
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Antibacterial Drugs Market - Forecasts to 2026 here
News-ID: 2356294 • Views: 388
More Releases from Global Market Estimates Research & Consultants
Global Environmental Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Environmental Monitoring Market is projected to grow at a CAGR value of 6.4% from 2023 to 2028. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on "Global Environmental Monitoring Market - Forecast to 2028'' https://www.globalmarketestimates.com/market-report/environmental-monitoring-market-3925 Merck KGaA, 3M, Honeywell International Inc., Thermo Fisher Scientific Inc, Emerson Electric Co., Danahar
Global Offshore Wind Turbines Market
According to a new market research report published by Global Market Estimates, the Offshore Wind Turbines Market is projected to grow at a CAGR of 8.2% from 2023 to 2028. The market for offshore wind turbines is expected to be driven by the growing need to switch from conventional to renewable energy sources. When compared to newly constructed coal or gas plants, solar and wind power generation are now thought to
Energy Trading and Risk Management (ETRM) Market Size
According to a new market research report published by Global Market Estimates, the Global Energy Trading and Risk Management (ETRM) Market is projected to grow at a CAGR of 6.5% from 2023 to 2028. Allegro Development Corporation, Amphora Inc., Triple Point Technology Inc., Openlink LLC., Eka Software Solutions, SAP, Sapient, Ventyx and Trayport among others, are some of the key players in the global energy trading and risk management (ETRM) market.
Global Custom Manufacturing of Chemical Products Market
According to a new market research report published by Global Market Estimates, the global custom manufacturing of chemical products market is projected to grow at a CAGR of 9.2% from 2023 to 2028. Connect Chemicals, Chemplast Sanmar Limited, Capital Resin Corporation, Baze Chemical, Proionics, Dorf Ketal, StarChem, Evonik Industries, WeylChem Group, Inventys, FutureFuel Corp., SOCMA, Regis Technologies, PHT International, SGRL, Chemcon Speciality Chemicals Ltd , Moehs Fine Chemicals, Optima Chemical, NOVASEP,
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market. Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug